Live news stream
José Mourinho is to leave Real Madrid at the end of the season, the club has confirmed at a press conference. It added that it no agreement yet with any other coach.
For more on this story visit ITV Football.
An ITV News investigation has found that the families of those killed after a garment factory collapsed in Bangladesh last month are still waiting for financial compensation from the Western clothes companies the factory supplied.
More than 1,100 people were killed and more than 2,500 injured after the eight-storey Rana Plaza factory building near Dhaka, Bangladesh collapsed on April 24.
Business Editor Laura Kuenssberg reports.
Criminal suspects who have been arrested should not be named until they are charged except for in 'clearly identified circumstances' such as a threat to life. That's according to official guidance issued to police forces in the wake of the Leveson Inquiry.
The recently formed professional standards body the College of Policing approved the guidance tonight following criticism about differing approaches to releasing information by forces.
The college says that at the point of charge, forces can release name, address, occupation and charge details, and must consult the Crown Prosecution Service (CPS) if they want to withhold the name.
MPs are debating the Coaliton's controversial plans for gay marriage in the Commons this evening. Knowing he'd lost support for the plans from his own side to lose, the Prime Minister has cut a deal with Labour to get it though.
The temporary pact should see this historic measure through the Commons.
Political Correspondent Libby Weiner reports:
The first opinion poll has been released since allegations emerged that a senior Tory aide described grassroots activists as "swivel-eyed loons".
- Conservative: 24% (-5)
- Labour: 35% (-1)
- Liberal Democrat: 11% (-1)
- UKIP: 22% (+6)
- Other: 8% (nc)
Parkinson's UK have said it is "too soon to know effects" the common diabetes drug Exenatide will have on the treatment of Parkinson's disease.
– Claire Bale, Research Communications Manager at Parkinson’s UK
This new research is a huge step forward in the on-going fight to find a drug which can slow down, or even halt, the progression of Parkinson's.
Despite these encouraging results, it is simply too soon to tell whether this drug is a blind alley or a breakthrough for people with Parkinson's.
The research was conducted in a very small number of people and, crucially, without a placebo group – making it difficult to draw too many firm conclusions at this stage.
We look forward to seeing the results of a much larger trial to fully examine the usefulness of exenatide for people with Parkinson's.
A diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research has found.
– Professor Roger Barker, University of Cambridge
This new study is perhaps more noteworthy for the approach it has taken with respect to the clinical trial design.
All of this was done in a modest number of patients and the results compared with a matched control arm that received best medical therapy.
Using this approach they found a signal of effect that suggested that the drug may well be slowing down the disease process.
All of which is good news not only for patients with PD but for us all, as we seek to explore how drugs already out there could be repositioned.